If either TNFα or IFNγ signaling in tumor-infiltrating CD4+ T cells is absent upon antigen recognition, tumor progression is stimulated, whereas combined TNFα and IFNγ signaling in CD4+ T cells prevents tumor angiogenesis and tumor-cell proliferation (59). The gene discussed is IFNG; the disease is neoplasm.